Sunshine Biopharma is a pharmaceutical company. Co.'s proprietary drug development activities are focused on the development of a small molecule called Adva-27a for the treatment of aggressive forms of cancer. Co.'s Canadian wholly owned subsidiary, Sunshine Biopharma Canada Inc. has licensing agreements with a primary pharmaceutical company for four prescription generic drugs for the treatment of breast cancer, prostate cancer and enlarged prostate. These four generic products are Anastrozole, Letrozole, Bicalutamide, and Finasteride. Co. develops Essential 9™, a dietary supplement comprised of the nine amino acids which the human body cannot synthesize. We show 7 historical shares outstanding datapoints in our SBFM shares outstanding history coverage, used to compute SBFM market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing SBFM market cap history over the course of time is important for investors
interested in comparing SBFM's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of SBFM versus a peer is one thing; comparing
SBFM market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like SBFM can fluctuate over the course of history.
With this page we aim to empower investors researching SBFM by allowing them to research the SBFM market cap history. |
Free SBFM Email Alerts:
Video: The Importance of Market Cap
